Frequency and diversity of Class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study
Authors:
- C. De ChampsCCC. De Champs
- C. ChanalCCC. Chanal
- D. SirotDSD. Sirot
- R. BaraducRBR. Baraduc
- J. P. RomaszkoJRJ. P. Romaszko
- R. BonnetRBR. Bonnet
- A. PlaidyAPA. Plaidy
- M. BoyerMBM. Boyer
- E. CarroyECE. Carroy
- M. C. GbadamassiMGM. C. Gbadamassi
- S. LaluqueSLS. Laluque
- O. OulesOOO. Oules
Open Access
- 1 September 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 54 (3) , 634-639
Abstract
Objectives: To evaluate the frequency and diversity of extended-spectrum β-lactamases (ESBLs) produced by Enterobacteriaceae and Pseudomonas aeruginosa in one French region. Methods: During 2001–2002, all the non-duplicate isolates of P. aeruginosa resistant to ceftazidime and of Enterobacteriaceae intermediate or resistant to ceftazidime and/or cefotaxime and/or aminoglycosides with an AAC(6′) I phenotype were collected in nine hospitals of the area. ESBL isoelectric points were determined, bla genes were amplified and sequenced and epidemic isolates were genotyped with ERIC2-PCR. Results: ESBLs were observed in 297 Enterobacteriaceae (0.8%). The most frequent were TEM-3 like (n=152; 51.2%) and TEM-24 (n=115; 38.7%). Four new enzymes were observed, TEM-112 (pI 5.4), TEM-113 (pI 6.3), TEM-114 (pI 5.9) and TEM-126 (pI 5.4). Other TEMs were TEM-8, TEM-12, TEM-16, TEM-19, TEM-20, TEM-21, TEM-29 and TEM-71. The other ESBLs were SHV-4, SHV-5 and SHV-12, CTX-M-1, CTX-M-3, CTX-M-14 and CTX-M-15. In 37 P. aeruginosa (0.7%) only one ESBL was observed, PER-1. Five epidemic strains were detected, Serratia marcescens TEM-3 and four observed in several hospitals, Enterobacter aerogenes TEM-24, Citrobacter koseri TEM-3, Proteus mirabilis TEM-3 and P. aeruginosa PER-1. Conclusion: ESBL frequency was lower than in 1998, and CTX-M-type frequency higher (2.1% of ESBLs in 2001, 4.9% in 2002). This long-term survey detected new sporadic enzymes (TEM-112, TEM-113, TEM-114 and TEM-126) and interhospital epidemic strains while avoiding any overestimation of ESBL frequency that may otherwise have occurred because of acute epidemics.Keywords
This publication has 28 references indexed in Scilit:
- Salmonella enterica Serovar Typhimurium bla PER-1 -Carrying Plasmid pSTI1 Encodes an Extended-Spectrum Aminoglycoside 6′- N -Acetyltransferase of Type IbAntimicrobial Agents and Chemotherapy, 2003
- Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in VietnamAntimicrobial Agents and Chemotherapy, 2002
- Prospective Survey of β-Lactamases Produced by Ceftazidime- Resistant Pseudomonas aeruginosa Isolated in a French Hospital in 2000Antimicrobial Agents and Chemotherapy, 2002
- Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→GlyAntimicrobial Agents and Chemotherapy, 2001
- A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in FranceAntimicrobial Agents and Chemotherapy, 2000
- Cefotaxime-Resistant Enterobacteriaceae Isolates from a Hospital in Warsaw, Poland: Identification of a New CTX-M-3 Cefotaxime-Hydrolyzing β-Lactamase That Is Closely Related to the CTX-M-1/MEN-1 EnzymeAntimicrobial Agents and Chemotherapy, 1998
- Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter studyAntimicrobial Agents and Chemotherapy, 1997
- Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1993
- Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel β-lactamaseJournal of Antimicrobial Chemotherapy, 1987